DUO Q2 2021 Earnings Massive EPS Miss Sends Shares Lower QGEN Q1 2026 Earnings EPS Misses Estimates Yet Shares Rise 166 AEON Biopharma Q4 2025 Earnings Major EPS Miss and No Revenue Weigh on Investor Sentiment NXST Q1 2026 Earnings Strong EPS Beat Amidst Modest Stock Decline as Nexstar Outperforms Estimates Vaxcyte PCVX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CLIR Q1 2026 Earnings WiderthanExpected Loss Reflects Continued PreRevenue Development